Replies to post #110303 on Biotech Values

[oldberkeley]

There are a couple of factors that I think suggest this one will price and close quickly.

I'd have to add what I think is the most important factor: the subscribers are virtually certain that Teva is bluffing (lying) and better days are ahead for MNTA's PPS.

[go seek]

MNTA: a guess on the offering price?

i say $15.25 or +

another note... i think MNTA has decided not to let the dust settle on their shoes and is moving to raise cash to get other 'promising' drugs into the clinic in a timely manner i.e. partnership.

This offering should not (necessarily) be viewed as a negative event.

link to previous financing: #msg-41777300
4,000,000 shares at a price of $10.75 per share on 28 Sept / 2009

[zipjet]

The key will be how quickly the pricing is announced and that the shares are fully subscribed.

There are a couple of factors that I think suggest this one will price and close quickly.

It priced quickly. Considering the size and trading today, I think we should see this closed by Tuesday.

This should put in the bottom absent another event.

JMHO

ij